 |
Government signs agreement with BioNTech SE to provide up to 10,000 patients with precision cancer immunotherapies by 2030 NHS England’s new Cancer Vaccine Launch Pad aims to improve access to personalised treatments and clinical trials BioNTech SE to set up laboratories and a regional hub in England to support the development of immunotherapies Ground-breaking Continue reading MAJOR AGREEMENT TO DELIVER NEW CANCER VACCINE TRIALS
Genomics England has completed installation of an enterprise imaging system that will help to support a world-pioneering initiative for cancer research. The programme is linking whole genome sequencing, pathology and radiology data, in what has been described as the world’s largest multimodal cancer research platform. First announced in 2022 as a means Continue reading Genomics England deploys Sectra imaging technology in ground-breaking cancer data programme
|
NEED AN UP TO DATE DATABASE? 
 |
Recent Comments